Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient
Author:
Affiliation:
1. Department of Dermatology; Tokyo Medical University; Tokyo Japan
2. Department of Ophthalmology; Tokyo Medical University; Tokyo Japan
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13612/fullpdf
Reference5 articles.
1. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol,2015
2. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes;Freeman-Keller;Clin Cancer Res,2016
3. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens;Sugita;Invest Ophthalmol Vis Sci,2006
4. Ipilimumab-induced ocular and orbital inflammation-a case series and review of the literature;Papavasileiou;Ocul Immunol Inflamm,2016
5. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410;Shindo;Br J Ophthalmol,1994
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. VKH-like uveitis during donafenib therapy for hepatocellular carcinoma: a case report and review of the literature;Frontiers in Pharmacology;2024-07-18
2. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review;Diagnostics;2024-02-04
3. Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma;Melanoma Research;2023-10-02
4. HLA-DRB1*04:05 is involved in the development of Vogt–Koyanagi–Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors;Scientific Reports;2023-08-21
5. Update on Immune Checkpoint Inhibitor-Associated Uveitis;Current Ophthalmology Reports;2023-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3